iCAD to Present at SunTrust Robinson Humphrey's 37th Annual Institutional UnConference

Saturday, April 12, 2008 General News J E 4
NASHUA, N.H., April 11 iCAD, Inc.(Nasdaq: iCAD), an industry-leading provider of Computer-Aided Detection (CAD)solutions for the early identification of cancer, today announced that KenFerry, President and Chief Executive Officer and Darlene Deptula-Hicks,Executive Vice President and Chief Financial Officer, will be giving acorporate presentation at SunTrust Robinson Humphrey's 37th AnnualInstitutional UnConference on Wednesday, April 16, 2008 at 8:00 a.m. EDT atthe Ritz Carlton, Buckhead in Atlanta, Georgia.

SunTrust Robinson Humphrey's 37th Annual Institutional UnConferenceconnects company executives and management teams with investors, whereinvestors will have the opportunity to personally meet with management teamsin intimate one-on-one and small group meetings.

About iCAD, Inc.

iCAD, Inc. is an industry-leading provider of Computer-Aided Detection(CAD) solutions that enable healthcare professionals to better serve patientsby identifying pathologies and pinpointing cancer earlier. iCAD offers acomprehensive range of high-performance, upgradeable CAD systems for the high,mid and low volume mammography markets. iCAD is entrusted with the task ofearly cancer detection by more than 2,000 women's healthcare centersworldwide. For more information, call +1 877 iCADnow or visit

For iCAD Investor Relations, contact Anne Marie Fields of Lippert/Heilshorn &

Associates at 212-838-3777 x6604 or via email at

For iCAD Public Relations, contact Jill Testagrossa of Schwartz CommunicationsFor iCAD, contact Darlene Deptula-Hicks, EVP and CFO at 603-882-5200 x7944 or via email at



You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
April 15 is Deadline for Input on State Aging Plan
PreMD Provides Update on FDA Review